Global Fundus Photography Market Size By Type (Hand-Held Fundus Cameras, Bench-Top Fundus Cameras), By Application (Hospitals, Eye Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Fundus Photography Market was valued at USD 540 million in 2023 and is projected to surpass USD 990 million by 2031, expanding at a CAGR of 7.8% during 2023–2031. This growth is fueled by the increasing prevalence of retinal disorders such as diabetic retinopathy and age-related macular degeneration (AMD), as well as the expanding use of fundus imaging in routine ophthalmic diagnostics. Technological innovations including portable and smartphone-based fundus cameras, coupled with AI-powered diagnostic platforms, are also playing a pivotal role in market expansion.

Drivers:

1. Rising Incidence of Eye Diseases:

Globally, there is a surge in diabetes-related eye complications and aging populations—two key risk factors for retinal diseases. Early detection and regular monitoring via fundus photography is driving its demand.

2. Technological Innovations:

Emergence of non-mydriatic, handheld, and AI-integrated fundus cameras has significantly improved diagnostic accuracy and portability, leading to broader adoption in remote and primary care settings.

3. Growing Use in Teleophthalmology:

The integration of fundus photography in telemedicine workflows has increased access to ophthalmic care in underserved and rural regions, boosting market uptake.

Restraints:

1. High Equipment Cost:

Despite technological advancements, the initial capital investment required for advanced fundus cameras remains a barrier for smaller clinics and developing healthcare systems.

2. Lack of Trained Personnel:

Proper operation of fundus photography devices and interpretation of retinal images requires specialized training, which is lacking in some regions, limiting market penetration.

Opportunity:

1. Expansion in Emerging Markets:

Rising healthcare awareness and infrastructure improvements in Asia-Pacific, Latin America, and Africa are creating new opportunities for market players.

2. Integration with AI Diagnostics:

Collaborations with AI firms for automated retinal screening tools offer growth prospects for manufacturers looking to diversify their product offerings and target mass screening programs.

Market by System Type Insights:

In 2023, Non-Mydriatic Fundus Cameras dominated the market due to their ease of use, reduced patient discomfort, and suitability for high-throughput screening. These systems are increasingly deployed in both primary care clinics and mobile diagnostic units. However, the Smartphone-based Fundus Cameras segment is projected to register the fastest growth, propelled by affordability and adoption in low-resource settings.

Market by End-Use Insights:

Hospitals & Ophthalmic Clinics emerged as the leading end-use segment in 2023, accounting for over 60% of the global revenue. This dominance is attributed to the high patient inflow for routine eye exams and specialized retinal care. The Ambulatory Surgical Centers (ASCs) and Diagnostic Laboratories segments are expected to witness accelerated growth due to the push for outpatient diagnostics and decentralized care.

Market by Regional Insights:

North America led the global fundus photography market in 2023, driven by advanced healthcare infrastructure, high awareness levels, and early adoption of AI-enabled ophthalmic diagnostics. Asia-Pacific is poised to exhibit the highest CAGR during the forecast period, supported by rising diabetic population, aging demographics, and expanding healthcare access in countries such as China and India.

Competitive Scenario:

Key players in the Global Fundus Photography Market include Topcon Corporation, Carl Zeiss Meditec AG, Canon Inc., NIDEK Co., Ltd., Optomed Oy (Ltd), Kowa Company Ltd., CenterVue SpA, Eyenuk Inc., and Remidio Innovative Solutions Pvt. Ltd. These companies are actively investing in R&D, strategic partnerships, and geographic expansion to bolster their market position.

Key Market Developments:

2023: Topcon Corporation launched a next-gen non-mydriatic fundus camera integrated with cloud connectivity for seamless data transfer in teleophthalmology.

2023: Eyenuk Inc. received FDA clearance for its AI-powered EyeArt® system for autonomous diabetic retinopathy screening.

2024: Canon Inc. introduced a compact fundus camera with AI-based anomaly detection aimed at primary care integration.

Scope of Work – Global Fundus Photography Market

Report Metric Details

Market Size (2023) USD 540 million

Projected Market Size (2031) USD 990 million

CAGR (2023–2031) 7.8%

Market Segments